Sender CO & Partners, Inc. Immutep LTD Transaction History
Sender CO & Partners, Inc.
- $297 Million
- Q3 2025
A detailed history of Sender CO & Partners, Inc. transactions in Immutep LTD stock. As of the latest transaction made, Sender CO & Partners, Inc. holds 215,861 shares of IMMP stock, worth $401,501. This represents 0.13% of its overall portfolio holdings.
Number of Shares
215,861
Previous 122,754
75.85%
Holding current value
$401,501
Previous $201,000
93.03%
% of portfolio
0.13%
Previous 0.11%
Shares
2 transactions
Others Institutions Holding IMMP
# of Institutions
37Shares Held
2.35MCall Options Held
1.28KPut Options Held
20K-
Black Rock Inc. New York, NY839KShares$1.56 Million0.0% of portfolio
-
Meridian Wealth Management, LLC421KShares$782,8740.03% of portfolio
-
Morgan Stanley New York, NY166KShares$308,6960.0% of portfolio
-
Susquehanna International Group, LLP Bala Cynwyd, PA95.3KShares$177,1720.0% of portfolio
-
Verition Fund Management LLC Greenwich, CT75KShares$139,5000.0% of portfolio
About IMMUTEP Ltd
- Ticker IMMP
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 86,624,000
- Market Cap $161M
- Description
- Immutep Limited, a biotechnology company, engages in the research and development of pharmaceutical product candidates. The company develops immunotherapeutic products for the treatment of cancer and autoimmune diseases. Its lead product candidate is eftilagimod alpha (efti or IMP321), a recombinant protein that is in Phase IIb clinical trial as...